Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9603 |
High Similarity |
NPD3027 |
Phase 3 |
0.9231 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.9231 |
High Similarity |
NPD1613 |
Approved |
0.8923 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8846 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8397 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8397 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8321 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.8284 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8243 |
Intermediate Similarity |
NPD1934 |
Approved |
0.824 |
Intermediate Similarity |
NPD228 |
Approved |
0.8222 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8219 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8217 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8106 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8102 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8065 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8065 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8065 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7986 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7985 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7969 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7961 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7961 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7911 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7902 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7891 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7883 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7867 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7867 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7862 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7862 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7857 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7848 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7846 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7836 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7823 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7763 |
Intermediate Similarity |
NPD37 |
Approved |
0.773 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7727 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7727 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7721 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7718 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7714 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7704 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7702 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7692 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7687 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7671 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7671 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7656 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7656 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7655 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7654 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7638 |
Intermediate Similarity |
NPD290 |
Approved |
0.7625 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7612 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7607 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7606 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7586 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7574 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7568 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7564 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7559 |
Intermediate Similarity |
NPD968 |
Approved |
0.7551 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7551 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7551 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7551 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7533 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.752 |
Intermediate Similarity |
NPD291 |
Approved |
0.7517 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7517 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7467 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7463 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.745 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7447 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD6671 |
Approved |
0.744 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7438 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7429 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7426 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7426 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7413 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD8651 |
Approved |
0.74 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7386 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7383 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7372 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7351 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7325 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7315 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.731 |
Intermediate Similarity |
NPD5735 |
Approved |
0.731 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.731 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7297 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7292 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7267 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7267 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7261 |
Intermediate Similarity |
NPD5772 |
Approved |
0.726 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7255 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7248 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7214 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7214 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7214 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7197 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7181 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7172 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7153 |
Intermediate Similarity |
NPD3180 |
Approved |
0.7153 |
Intermediate Similarity |
NPD3179 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3052 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7143 |
Intermediate Similarity |
NPD52 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3054 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7123 |
Intermediate Similarity |
NPD3062 |
Approved |
0.7123 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD3059 |
Approved |
0.7123 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7122 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7114 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7114 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7114 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7109 |
Intermediate Similarity |
NPD940 |
Approved |
0.7109 |
Intermediate Similarity |
NPD846 |
Approved |
0.7107 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7107 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7105 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7103 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7101 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7101 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD821 |
Approved |
0.709 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7083
|
Intermediate Similarity |
NPD7549 |
Discontinued |